Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00393055 · ClinicalTrials.gov registry record · Phase 3
Xylitol Adult Caries Trial (X-ACT)
A Phase 3 study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 3
- Development phase
- 709
- Enrollment target
NCT00393055 is a Phase 3 study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 709 participants.
The verdict
NCT00393055, a Phase 3 study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 709 participants
- Enrollment target
Study Summary
The purpose of the trial is to determine the extent to which daily use of xylitol lozenges reduces the appearance of new caries lesions in adults who tend to experience such lesions (i.e., caries-active adults).
Interventions
- DIETARY_SUPPLEMENT xylitol
- DIETARY_SUPPLEMENT inactive lozenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 709 participants |
| Start Date | 2007-01 |
| Est. Completion | 2011-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00393055
The ClinicalTrials.gov registry entry for NCT00393055 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 709 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which xylitol is the first listed.
NCT00393055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00393055 about?
NCT00393055 is a clinical study titled "Xylitol Adult Caries Trial (X-ACT)". The purpose of the trial is to determine the extent to which daily use of xylitol lozenges reduces the appearance of new caries lesions in adults who tend to experience such lesions (i.e., caries-active adults).
What is the current status of trial NCT00393055?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 709 participants. The study started on 2007-01. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00393055?
The interventions under investigation include: xylitol (DIETARY_SUPPLEMENT), inactive lozenge (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00393055?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.